How many institutions own GLMD stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GLMD shares is 17, representing 1.42% of the company's common stock.

Who are the major shareholders selling Galmed Pharmaceuticals Ltd. stock?

, in the last quarter, reduced its stake in GLMD by -100% restricting it's holding to 0 shares of worth nearly -. STONEX GROUP INC. also lessened -100% of the GLMD shares from its portfolio, reducing its holding to 0 shares of worth -. MILLENNIUM MANAGEMENT LLC also shunned GLMD shares holding by -11.79% last quarter which brought its holding to 131.63 thousand shares worth $56.00K.

Investors who are buying GLMD stock?

As per its latest 13F filing, VIRTU FINANCIAL LLC increased its stake in GLMD by 100% in the last quarter. The institutional holder raised its holding to 31.63 thousand shares having worth more than $13.00K. NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO also added 100% more shares of GLMD to its portfolio, raising its holding to 10 shares of worth $4.00. MORGAN STANLEY also increased its GLMD shares holding by 13.01% which brought its holding to 204.25 thousand shares worth $87.11K.

GLMD's major insiders: who are they?

The insider with the most stakes in GLMD is N/A , N/A at the company. Additionally, GLMD stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell GLMD stock?

Company executives, directors, and other insiders own 1.19% percent of Galmed Pharmaceuticals Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which GLMD insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased GLMD stock?

There have been 0 transaction(s) during the past 6-months in which Galmed Pharmaceuticals Ltd. insiders have bought stock, totalling 0 shares

How much of GLMD does insiders own?

Around 0 Galmed Pharmaceuticals Ltd. shares are held by insiders, which represents about 1.19% of GLMD stock.

Who is the insider with the largest stake?

GLMD N/A, N/A holds the largest portfolio of the company's shares. GLMD shares owned by N/A total nearly -.

Which institution holds the most shares in GLMD?

is the largest institutional owner in GLMD which holds 0 shares worth - or 0% of the total GLMD shares outstanding followed by STONEX GROUP INC. with ownership of 0 shares representing 0% of the GLMD ownership. VIRTU FINANCIAL LLC is the third largest stakeholder with 31.63 thousand shares or 1.88% of the ownership worth more than $13.00K.

Is Galmed Pharmaceuticals Ltd. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GLMD is concerned, it is a stock which is not optionable.

Is there a short position on GLMD's shares?

Number of GLMD shares short is 46.32K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding GLMD shares are there?

As of today, 5.46M shares of GLMD are outstanding.

Is there many float in GLMD stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GLMD has 2.23M shares in float.

GLMD short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GLMD is 0.13.

Stock Ideas

GLMD Stock Ownership Breakdown

NASDAQ : GLMD

Galmed Pharmaceuticals

$0.61

-0.0003-0.05%

At Close 4:00 PM

65.09

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.85

Short Percent Of Float0.86

Shares Outstanding5.46M

Shares Float2.23M

Shares Short46.32K

Short Ratio0.13

0.86%

Short % of Float

0.85%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

1.19% Percentage of Shares held by All Insiders

1.42% Percentage of Shares held by All Institutions

1.44% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 1.42% of GLMD shares are held by financial institutions. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Galmed Pharmaceuticals Ltd. is owned by the company. STONEX GROUP INC. owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2023		0%	0	-	-1K	-100.00%
Mar 31, 2023	STONEX GROUP INC.	0%	0	-	-10.56K	-100.00%
Mar 31, 2023	VIRTU FINANCIAL LLC	1.88%	31.63K	13K	31.63K	+100.00%
Mar 31, 2023	RAYMOND JAMES & ASSOCIATES	8.22%	138.04K	58.87K	0	0
Mar 31, 2023	MILLENNIUM MANAGEMENT LLC	7.83%	131.63K	56K	-17.59K	-11.79%
Mar 31, 2023	BELPOINTE ASSET MANAGEMENT LLC	0.84%	14.05K	5.99K	0	0
Mar 31, 2023	ACCURATE WEALTH MANAGEMENT, LLC	0%	0	-	-1.11K	-100.00%
Mar 31, 2023	TD WATERHOUSE CANADA INC.	0%	0	-	-1K	-100.00%
Mar 31, 2023	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0%	0	-	0	0
Mar 31, 2023	GROUND SWELL CAPITAL, LLC	0%	0	-	-10.36K	-100.00%
Mar 31, 2023	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0%	10	4	10	+100.00%
Mar 31, 2023	WESTERN WEALTH MANAGEMENT, LLC	1.76%	29.54K	12.6K	0	0
Mar 31, 2023	BVF INC/IL	80.21%	1.35M	574.82K	-391.92K	-22.53%
Mar 31, 2023	MORGAN STANLEY	12.16%	204.25K	87.11K	23.52K	+13.01%
Mar 31, 2023	CITADEL ADVISORS LLC	2.43%	40.84K	17.42K	40.84K	+100.00%
Mar 31, 2023	CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	1.7%	28.5K	12K	0	0
Mar 31, 2023	RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	1.66%	27.9K	11.9K	0	0
Mar 31, 2023	BNP PARIBAS ARBITRAGE, SNC	0.82%	13.72K	5.85K	13.12K	+2,186.00%
Mar 31, 2023	JANE STREET GROUP, LLC	0.79%	13.19K	5.63K	-14.03K	-51.55%
Mar 31, 2023	WELLS FARGO & COMPANY/MN	0.18%	3.05K	1.3K	0	0
Mar 31, 2023	FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.15%	2.5K	1.07K	0	0
Mar 31, 2023	BOURGEON CAPITAL MANAGEMENT LLC	0.03%	500	214	0	0
Mar 31, 2023	ALLWORTH FINANCIAL LP	0.01%	250	107	250	+100.00%
Mar 31, 2023	UBS GROUP AG	0.26%	4.31K	1.84K	-17.13K	-79.90%
Mar 31, 2023	TSFG, LLC	0.18%	3K	1K	0	0
Mar 31, 2023	ZRC WEALTH MANAGEMENT, LLC	0.01%	100	43	100	+100.00%
Mar 31, 2023	BENJAMIN F. EDWARDS & COMPANY, INC.	0%	0	-	-200	-100.00%
Mar 31, 2023	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-10K	-100.00%
Mar 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	1.62%	27.18K	11.59K	0	0

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.